US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

F/m Emerald Life Sciences Innovation ETF

48.06

+0.57331.21%

Post-market: 47.11-0.9528-1.98%19:30 EDT

Volume:5K

Turnover:221.35K

Market Cap:132.51M

PE:- -

High:48.19

Open:48.00

Low:47.87

Close:47.49

52wk High:48.78

52wk Low:27.34

Shares:2.76M

Float Shares:2.76M

Volume Ratio:1.31

T/O Rate:0.17%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Cancer Blood Screen Spac's Merger is Delayed by Test's Results

Guardant Health to Report Q2 2026 Results After Market Close, Host Conference Call

Guardant Health is Maintained at Overweight by Morgan Stanley

Guardant Health price target raised to $175 from $130 at Morgan Stanley

Guardant Health is Maintained at Buy by Citigroup

Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis

Guardant Health price target raised to $215 from $150 at Citi

StemRIM Wins South Korean Patent for Gene Therapy Targeting Rare Skin Disorder

US FDA Approves Vera's Kidney Disease Drug

HANXBIO-B Forges Strategic Alliance to Pioneer AI-Enhanced Drug Discovery Framework

Everest Medicines Closes Exclusive Licensing, Collaboration Deal with Travere for Us$112.5 Million Upfront

BofA Securities Adjusts Price Target on Guardant Health to $190 From $135

MT Newswires Live

Travere Therapeutics (TVTX) Could Be 3% Undervalued As Russell Value Exits Stir Questions

Simply Wall St.

Guardant Health is Maintained at Buy by B of a Securities

Guardant Health price target raised to $190 from $135 at BofA

Guardant Health (GH) Is Up 12.6% After India Shield Cancer Test Deal And UnitedHealth Coverage Expansion

Simply Wall St.

LivaNova (LIVN) Joins Russell Indexes, Is The Stock Fully Priced?

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT) and Guardant Health (GH)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/LFSC/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LFSC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LFSC\",,,,,undefined,":{"symbol":"LFSC","market":"US","secType":"STK","nameCN":"F/m Emerald Life Sciences Innovation ETF","latestPrice":48.0628,"timestamp":1787688000000,"preClose":47.4895,"halted":0,"volume":4612,"hourTrading":{"tag":"盘后","latestPrice":47.11,"preClose":48.0628,"latestTime":"19:30 EDT","volume":194,"amount":9205.2812,"timestamp":1787700602165,"change":-0.9528,"changeRate":-0.019824,"amplitude":0.019142},"delay":0,"changeRate":0.012072142263026633,"floatShares":2757035,"shares":2757035,"eps":0,"marketStatus":"Closed","change":0.5733,"latestTime":"08-25 16:00:00 EDT","open":48,"high":48.19,"low":47.87,"amount":221346.80604,"amplitude":0.006738,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":47.4895,"sharesOutstanding":2657035,"nav":47.45,"aum":130821310.75,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":47.11,"preClose":48.0628,"latestTime":"19:30 EDT","volume":194,"amount":9205.2812,"timestamp":1787700602165,"change":-0.9528,"changeRate":-0.019824,"amplitude":0.019142},"volumeRatio":1.311494},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LFSC\",,,,,undefined,":{"symbol":"LFSC","floatShares":2757035,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.311494,"shares":2757035,"dividePrice":0,"high":48.19,"amplitude":0.006738,"preClose":47.4895,"low":47.87,"week52Low":27.3402,"pbRate":"--","week52High":48.78,"institutionHeld":0,"latestPrice":48.0628,"eps":0,"divideRate":0,"volume":4612,"delay":0,"ttmEps":0,"open":48,"prevYearClose":36.6147,"prevWeekClose":47.7953,"prevMonthClose":45.55,"prevQuarterClose":45.2033,"fiveDayClose":47.489,"twentyDayClose":45.3952,"sixtyDayClose":39.3901},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LFSC\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LFSC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LFSC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LFSC\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2650451974","title":"Cancer Blood Screen Spac's Merger is Delayed by Test's Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2650451974","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650451974?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:24","pubTimestamp":1783628640,"startTime":"0","endTime":"0","summary":"Call Thursday's cancer test results mixed.Thursday was the day set for shareholders to approve the merger of special-purpose acquisition company Perceptive Capital Solutions with cancer screening firm","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","PCSC","LU0889565916.HKD","BK4588","GH","HELX","GRAL","GDOC","EKG","BK4196","GNOM","BK4139","LFSC","LU0320765992.SGD","BK4551","BK4585","BK4535","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650197453","title":"Guardant Health to Report Q2 2026 Results After Market Close, Host Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2650197453","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650197453?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:05","pubTimestamp":1783627546,"startTime":"0","endTime":"0","summary":"Guardant Health to report Q2 2026 results after market close, host conference callGuardant Health schedules second-quarter 2026 results for July 30, 2026.Conference call webcast set for July 30, 2026 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nNDL1VMHCJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","GNOM","GDOC","BK4535","BK4551","LU0320765992.SGD","EKG","GH","BK4196","LU0109394709.USD","LU0889565916.HKD","BK4585","PTH","HELX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650976358","title":"Guardant Health is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2650976358","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650976358?lang=en_us&edition=fundamental","pubTime":"2026-07-10 01:10","pubTimestamp":1783617000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings(END) Dow Jones NewswiresJuly 09, 2026 13:10 ET","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4551","BK4588","EKG","LFSC","PTH","GH","GNOM","HELX","LU0889565916.HKD","BK4535","LU0109394709.USD","LU0320765992.SGD","GDOC","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650893926","title":"Guardant Health price target raised to $175 from $130 at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2650893926","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650893926?lang=en_us&edition=fundamental","pubTime":"2026-07-09 19:00","pubTimestamp":1783594833,"startTime":"0","endTime":"0","summary":"Morgan Stanley raised the firm’s price target on Guardant Health (GH) to $175 from $130 and keeps an Overweight rating on the shares. The firm is u...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-175-from-130-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-175-from-130-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","BK4535","LU0109394709.USD","GNOM","BK4551","LFSC","PTH","BK4196","HELX","LU0320765992.SGD","GDOC","GH","BK4588","BK4585","EKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650999712","title":"Guardant Health is Maintained at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2650999712","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650999712?lang=en_us&edition=fundamental","pubTime":"2026-07-09 00:15","pubTimestamp":1783527300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings(END) Dow Jones NewswiresJuly 08, 2026 12:15 ET","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4551","BK4588","EKG","LFSC","PTH","GH","GNOM","HELX","LU0889565916.HKD","BK4535","LU0109394709.USD","LU0320765992.SGD","GDOC","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649993698","title":"Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2649993698","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649993698?lang=en_us&edition=fundamental","pubTime":"2026-07-08 19:35","pubTimestamp":1783510500,"startTime":"0","endTime":"0","summary":"Combined company plans to advance nebokitug, a first-in-class anti-CCL24 antibody, through a precision medicine Phase 2 trial in rheumatoid arthritis (RA) by leveraging Scipher’s AI Network Medicine p","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/08/3323986/0/en/Chemomab-Therapeutics-and-Precision-Medicine-Pioneer-Scipher-Medicine-Announce-Merger-Agreement-to-Advance-Nebokitug-in-an-AI-Powered-Phase-2-Trial-in-Rheumatoid-Arthritis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","BK4007","BMED","ARTY","AGIX","LU1894683348.USD","BK4208","LU2500361329.USD","LU2346227817.USD","AIPO","LU0949170772.SGD","LENZ","LU1894683264.USD","BK4588","LU0553294199.USD","CMS","LFSC","GDOC","RA","BK4585","VTHR","LU0661504455.SGD","LU2637428348.USD","CHAT","LU1003077747.HKD","QTOC","MEDX","BK4539","BK4139","LU0738911758.USD","LU0545039389.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649296091","title":"Guardant Health price target raised to $215 from $150 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2649296091","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649296091?lang=en_us&edition=fundamental","pubTime":"2026-07-08 18:45","pubTimestamp":1783507510,"startTime":"0","endTime":"0","summary":"Citi analyst Patrick Donnelly raised the firm’s price target on Guardant Health (GH) to $215 from $150 and keeps a Buy rating on the shares. Publis...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-215-from-150-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-215-from-150-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTH","EKG","HELX","GH","LFSC","GNOM","LU0320765992.SGD","BK4585","BK4551","BK4196","BK4535","GDOC","LU0889565916.HKD","LU0109394709.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649963787","title":"StemRIM Wins South Korean Patent for Gene Therapy Targeting Rare Skin Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2649963787","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649963787?lang=en_us&edition=fundamental","pubTime":"2026-07-08 14:54","pubTimestamp":1783493684,"startTime":"0","endTime":"0","summary":"StemRIM Inc. ( ($JP:4599) ) has shared an update. StemRIM Inc. has secured patent protection in South Korea for a stem cell gene therapy technology...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/stemrim-wins-south-korean-patent-for-gene-therapy-targeting-rare-skin-disorder?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/stemrim-wins-south-korean-patent-for-gene-therapy-targeting-rare-skin-disorder?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","SYNB","FBT","BK4585","GNOM","CNCR","IBBQ","USRD","LFSC","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649593132","title":"US FDA Approves Vera's Kidney Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2649593132","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649593132?lang=en_us&edition=fundamental","pubTime":"2026-07-08 00:39","pubTimestamp":1783442363,"startTime":"0","endTime":"0","summary":"US FDA approves Vera's kidney disease drugJuly 7 (Reuters)-The U.S. Food and Drug Administration has approved Vera Therapeutics'VERA.Odrug to treat patients with a potentially life-threatening kidney disease, the regulator said on Tuesday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4N4391JJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERA","BK4539","BK4588","LU2324357040.USD","BK4585","LFSC","TVTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173871150","title":"HANXBIO-B Forges Strategic Alliance to Pioneer AI-Enhanced Drug Discovery Framework","url":"https://stock-news.laohu8.com/highlight/detail?id=1173871150","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173871150?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:12","pubTimestamp":1783422743,"startTime":"0","endTime":"0","summary":"HANXBIO-B has announced a strategic partnership aimed at harnessing the power of artificial intelligence to revolutionize the drug development process.The company has entered into a formal agreement...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1173","SBIO","03378","WRND","ARTY","AGIX","AIPO","PBE","BBP","BK4588","GSKH","LFSC","GDOC","BK4585","VTHR","CHAT","QTOC","BK1535","IBB","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649985267","title":"Everest Medicines Closes Exclusive Licensing, Collaboration Deal with Travere for Us$112.5 Million Upfront","url":"https://stock-news.laohu8.com/highlight/detail?id=2649985267","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649985267?lang=en_us&edition=fundamental","pubTime":"2026-07-07 17:30","pubTimestamp":1783416607,"startTime":"0","endTime":"0","summary":"Everest Medicines closes exclusive licensing, collaboration deal with Travere for US$112.5 million upfrontEverest Medicines closed an exclusive license and collaboration agreement with Travere Therape","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL8dST5l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LFSC","TVTX","01952","BK1583","BK4139","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649291621","title":"BofA Securities Adjusts Price Target on Guardant Health to $190 From $135","url":"https://stock-news.laohu8.com/highlight/detail?id=2649291621","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649291621?lang=en_us&edition=fundamental","pubTime":"2026-07-06 20:38","pubTimestamp":1783341496,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) has an average rating of buy and mean price target of $156.35, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4196","GH","EKG","LU0320765992.SGD","GNOM","LU0109394709.USD","LFSC","GDOC","BK4551","BK4535","HELX","PTH","LU0889565916.HKD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649745621","title":"Travere Therapeutics (TVTX) Could Be 3% Undervalued As Russell Value Exits Stir Questions","url":"https://stock-news.laohu8.com/highlight/detail?id=2649745621","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649745621?lang=en_us&edition=fundamental","pubTime":"2026-07-06 20:27","pubTimestamp":1783340822,"startTime":"0","endTime":"0","summary":"Travere Therapeutics (TVTX) has been removed from several Russell value indices, a shift that can influence trading patterns as funds tracking these benchmarks adjust their positions and reassess exposure to the stock.\nSee our latest analysis for Travere Therapeutics.\nBeyond the index changes, Travere Therapeutics has seen a strong 90 day share price return of 79.73% and a very large 1 year total shareholder return of 289.73%. This indicates that momentum has been building recently from a low...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tvtx/travere-therapeutics/news/travere-therapeutics-tvtx-could-be-3-undervalued-as-russell","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tvtx/travere-therapeutics/news/travere-therapeutics-tvtx-could-be-3-undervalued-as-russell","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","LFSC","FFTY","TVTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649625281","title":"Guardant Health is Maintained at Buy by B of a Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2649625281","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649625281?lang=en_us&edition=fundamental","pubTime":"2026-07-06 19:04","pubTimestamp":1783335840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings(END) Dow Jones NewswiresJuly 06, 2026 07:04 ET","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","BK4551","GH","GNOM","LFSC","EKG","BK4588","GDOC","BK4196","BK4535","HELX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649760623","title":"Guardant Health price target raised to $190 from $135 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2649760623","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649760623?lang=en_us&edition=fundamental","pubTime":"2026-07-06 18:35","pubTimestamp":1783334117,"startTime":"0","endTime":"0","summary":"BofA raised the firm’s price target on Guardant Health (GH) to $190 from $135 and keeps a Buy rating on the shares. Guardant Health is expected to ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-190-from-135-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-190-from-135-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","LU0889565916.HKD","PTH","BK4585","BK4196","HELX","BK4588","LU0109394709.USD","GDOC","GH","EKG","GNOM","LFSC","LU0320765992.SGD","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649269091","title":"Guardant Health (GH) Is Up 12.6% After India Shield Cancer Test Deal And UnitedHealth Coverage Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2649269091","media":"Simply Wall St.","labels":["corporation","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649269091?lang=en_us&edition=fundamental","pubTime":"2026-07-05 12:28","pubTimestamp":1783225734,"startTime":"0","endTime":"0","summary":"In recent weeks, Zydus Lifesciences announced an exclusive agreement with Guardant Health to bring the Shield Multi-Cancer Detection blood test to India, supported by an MoU with Apollo Hospitals to offer this methylation-based screen for 10 common cancers in adults aged 45 and over.\nThis move extends Shield’s reach into a large, high‑mortality cancer market and further validates Guardant’s technology alongside its FDA Breakthrough Device Designation in the United States.\nWe’ll now examine...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-is-up-126-after-india-shield-cancer-test","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-is-up-126-after-india-shield-cancer-test","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","HELX","LU0889565916.HKD","LU0320765992.SGD","GDOC","PTH","BK4535","GNOM","EKG","BK4551","BK4585","BK4196","GH","LU0109394709.USD","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648985326","title":"LivaNova (LIVN) Joins Russell Indexes, Is The Stock Fully Priced?","url":"https://stock-news.laohu8.com/highlight/detail?id=2648985326","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648985326?lang=en_us&edition=fundamental","pubTime":"2026-07-04 03:25","pubTimestamp":1783106727,"startTime":"0","endTime":"0","summary":"What LivaNova’s Index Additions Could Mean for Liquidity and Demand\nLivaNova (NasdaqGS:LIVN) has been added to several Russell Growth and Small Cap benchmarks, an event that can influence trading volumes as index funds and institutional investors adjust their portfolios.\nFor you as a shareholder or prospective buyer, the key angle here is potential shifts in liquidity. Index inclusion often coincides with higher trading activity as passive funds that track these benchmarks buy shares to match...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-livn/livanova/news/livanova-livn-joins-russell-indexes-is-the-stock-fully-price","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-livn/livanova/news/livanova-livn-joins-russell-indexes-is-the-stock-fully-price","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2065169927.USD","BK4082","LIVN","LU2065171311.SGD","LU2065170008.USD","LFSC","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648409664","title":"Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT) and Guardant Health (GH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648409664","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648409664?lang=en_us&edition=fundamental","pubTime":"2026-07-03 22:50","pubTimestamp":1783090219,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on PROCEPT BioRobotics (PRCT) and Guardant Health (GH) ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-procept-biorobotics-prct-and-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-procept-biorobotics-prct-and-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRCT","HCSG","GH","LU0320765992.SGD","BK4588","EKG","BK4196","BK4535","XBI","LFSC","LU0128526141.USD","LU0109394709.USD","BK4581","LU0029874061.USD","LU0889565916.HKD","BK4551","LU2324357040.USD","XLV","HELX","LABU","BK4082","PTH","GDOC","GNOM","BK4585","BK4137"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":198,"code":"91000000","status":"200"}]}}